Remote Electrical Neuromodulation Articles & Analysis
7 news found
Worn on the upper arm, Nerivio utilizes remote electrical neuromodulation to induce the brain's native pain regulation mechanism, Conditioned Pain Modulation. ...
The prospective, multi-center, open-label trial (NCT04194008), evaluated the efficacy and safety of remote electrical neuromodulation (REN) for the acute treatment of migraine in chronic migraine patients. ...
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that the Centers for Medicare and Medicaid Services (CMS) published its most recent Level II Healthcare Common Procedure Coding System (HCPCS), assigning a new HCPCS Level II code K1023 "Distal Transcutaneous Electrical Nerve ...
Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced the publication of a study in Pain Medicine that compared adolescent response to migraine medications to their response to Remote Electrical Neuromodulation (REN) administered by Nerivio®. ...
"This study provides hope for the many women whose migraine headaches are associated with menstruation. The remote electrical neuromodulation therapy provides patients with a non-pharmaceutical option that is safe and effective. ...
"Over the last couple of years our toolbox for treating migraine has been enriched with several new types of FDA-authorized therapies, including a few drug-free neuromodulation devices," said Christopher Gottschalk, MD, a Yale Medicine neurologist and director of Yale Medicine's Headache and Facial Pain Center, who also serves as the president of the Alliance for Headache ...
Theranica's FDA-cleared prescribed therapeutic wearable Nerivio® is worn on the upper arm for 45 minutes, and utilizes Remote Electrical Neuromodulation to activate the brain's native Conditioned Pain Modulation mechanism to treat pain and associated migraine symptoms. ...